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ABSTRACT
Introduction: The adverse effects of induction opioids on the neonate are poorly characterised. The study aim was to investigate
whether induction opioids can be used in caesarean section without adversely affecting the neonate.
Methods: Six databases were systematically searched from inception until January 2019. Included studies compared induction opioids and placebo in caesarean section. Results were presented as odds ratios (95% conﬁdence intervals) for dichotomous outcomes
and weighted mean difference for continuous outcomes. An I2 statistic of >50% was signiﬁcant for heterogeneity. The primary
outcome was Apgar score (1 and 5 min). Secondary outcomes included neonatal adverse events, cord blood gas analyses, maternal
haemodynamic parameters (systolic blood pressure (SBP), mean arterial pressure (MAP), heart rate (HR) and catecholamine
concentrations.
Results: Seventeen studies (n=987) were included in the meta-analysis. Remifentanil 0.5–1 lg/kg or 2–3 lg/kg/h, alfentanil
7.5–10 lg/kg and fentanyl 0.5–1 lg/kg were compared to placebo. There was no signiﬁcant difference in Apgar scores at 1 min
(P=0.25, 0.58 and 0.89 respectively) for all three opioids or at 5 min for remifentanil and alfentanil (P=0.08 and 0.21 respectively).
Fentanyl signiﬁcantly reduced 5 min Apgar scores (P=0.002). There was no difference in neonatal airway interventions with
remifentanil or alfentanil (P <0.05). All three induction opioids caused a signiﬁcant reduction in maximum SBP (P <0.0001),
MAP (P <0.00001) and HR (P <0.00001).
Conclusion: Induction opioids are effective sympatholytic agents. Remifentanil and alfentanil appear to be safe, with no signiﬁcant
effect on Apgar scores or neonatal airway intervention, but a well-powered trial is required to conﬁrm these ﬁndings.
Ó 2019 Elsevier Ltd. All rights reserved.

Introduction
Caesarean section (CS) under general anaesthesia (GA)
is commonly performed due to surgical urgency, inadequate previous block, maternal refusal or contraindication to neuraxial anaesthesia.1 The induction of
general anaesthesia and initial surgical incisions cause
signiﬁcant sympathetic drive which may result in
adverse effects, for example intracranial haemorrhage
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in the context of comorbidities such as preeclampsia.2–5 For this reason sympatholysis is often
required on induction of general anaesthesia and initiation of CS. Opioids are highly effective sympatholytic
agents used at induction of general anaesthesia but are
often avoided due to their potential adverse effects on
the neonate.6–10 Recommendations to omit opioids from
the induction of anaesthesia are based on evidence from
the use of older, longer-lasting opioids.1 The newer,
shorter-acting opioids (e.g. remifentanil, alfentanil and
fentanyl) have been proposed as ‘safe’ options for the
induction of GA for CS. There has been one small
meta-analysis investigating the effect of remifentanil.11
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This study showed a high degree of efﬁcacy and no statistically signiﬁcant adverse effects, however the authors
also recommended further studies to clarify these ﬁndings. Since that meta-analysis, there have been a number
of randomised controlled trials (RCTs) performed to
investigate the use of remifentanil and other agents.
The primary aim of this review was to determine the
effect of induction opioids on Apgar scores. The secondary aim was to assess the effect on other neonatal
outcomes, as well as the efﬁcacy of induction opioids
for sympatholysis.

Methods
Search strategy
Two independent reviewers (AH and GA) searched the
Cochrane trials registry, SCOPUS, Medline, CINAHL,
PubMed and Web of Science from inception until January 2019. This search was conducted using the terms
(1) ‘opioid’ AND ‘Caesarean section’ OR ‘Cesarean section’; (2) ‘opioid’ AND ‘intubation’ AND ‘Caesarean
section’ OR ‘Cesarean section’; (3) ‘opioid’ AND ‘general anaesthesia’ AND ‘Caesarean section’. A manual
reference check and citation check of included papers
was performed to identify any additional studies.

Study eligibility
To be eligible for inclusion the authors were required to
report on the use of induction opioids for CS. Only
RCTs with a placebo control group were eligible and
there were no language criteria for exclusion. Two
reviewers (LW and AH) independently assessed and
agreed upon each study for inclusion in this systematic
review. Studies comparing induction opioids to alternative agents, studies using opioids only after cord clamping and studies of obstetric patients having operations
other than CS were excluded.

Data extraction
LW and AH extracted data from each article that met
the inclusion criteria independently. The extracted data
included the study design, patient characteristics and
clinical outcome results. The data collected by each
reviewer was then compared for homogeneity.

Clinical outcome measures
Our a priori primary outcomes were Apgar scores at one
and ﬁve minutes post delivery. Secondary outcomes
included neonatal adverse outcomes such as bag-maskventilation (BVM), intubation and neonatal intensive
care unit (NICU) admission, neonatal cord blood results
(pH and base excess (BE)), highest maternal systolic
blood pressure (SBP), mean arterial pressure (MAP)
and heart rate (HR), as well as maternal epinephrine
and norepinephrine concentrations.

Induction opioids for caesarean section

Level of evidence, risk of bias and outcome level of
evidence ranking
Each article was evaluated using the Centre for Evidence
Based Medicine (CEBM) Levels of Evidence Introduction Document.12 These studies were then assessed for
risk of bias and methodological quality using the
Cochrane Collaboration’s tool for assessing the risk of
bias.13 A study was deemed to be of low risk if it scored
four or more low-risk criteria on the risk of bias tool.
Studies were rated high risk if they scored three or less
low-risk criteria.

Statistical analyses
The combined data were analysed using RevMan 5.3
software (The Nordic Cochrane Centre, Copenhagen,
Denmark), using the risk ratio (RR) with 95% conﬁdence interval (CI) for dichotomous outcomes and the
weighted mean difference (WMD) with 95% CI for continuous outcomes. The Mantel-Haenszel (M-H) random
effects model was used. Heterogeneity was assessed
using the I2 statistic, with an I2 >50% indicating signiﬁcant heterogeneity. A P-value <0.05 provided evidence
of signiﬁcant RR and WMD. A P-value of <0.10 was
used to demonstrate heterogeneity of intervention
effects.

Reporting
This study was reported in line with PRISMA
guidelines.14

Results
Literature search results
The initial systematic search yielded 2138 citations and a
further six citations were identiﬁed through a manual
citation and reference search of relevant articles
(Fig. 1). Following the removal of duplicates, 1196 citations remained. Of these, 63 abstracts were screened and
29 full texts were retrieved for review. Seventeen articles
met the inclusion criteria (Fig. 1). These studies included
987 patients. All studies investigated the use of either
remifentanil, alfentanil or fentanyl versus placebo for
the induction of anaesthesia for CS (Table 1). The doses
used in these studies included remifentanil 0.5–1 lg/kg
bolus or 2–3 lg/kg/h infusion, alfentanil 7.5–10 lg/kg
bolus and fentanyl 0.5–1 lg/kg bolus. The study by
Deogaonkar et al. included intervention groups
0.5 lg/kg and 1 lg/kg fentanyl.17 These groups have
been analysed separately. The risk of bias in the studies
is shown in Fig. 2. Thirteen studies met the criteria for
high-quality RCTs, leaving four low-quality RCTs.

Primary outcomes
Overall, 12 studies measured Apgar score at one minute
post delivery and showed no signiﬁcant difference
(WMD 0.05; 95%CI 0.23 to 0.13; I2=65%; P=0.60;
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Fig. 1

The PRISMA diagram of trial selection

Fig. 3).7,9,15–24 Of these 12 studies, six investigated the
effect of remifentanil,16,18,20,22–24 three alfentanil9,15,21
and three fentanyl.7,17,19 When divided into the individual agents there was no signiﬁcant difference after
remifentanil (WMD
0.27; 95%CI
0.74 to 0.19;
I2=78%; P=0.25), alfentanil (WMD 0.05; 95%CI
0.12 to 0.21; I2=0%; P=0.58) or fentanyl (WMD
0.02; 95%CI 0.30 to 0.26; I2=72%; P=0.89).
The same 12 studies investigated Apgar scores at ﬁve
minutes post delivery, again showing no signiﬁcant
effect overall (WMD 0.11; 95%CI 0.22 to 0.01;
I2=81%; P=0.07; Fig. 4).7,9,15–24 Fentanyl was the only
opioid to show a signiﬁcant reduction in Apgar scores
(WMD
0.20; 95%C
0.33 to
0.08; I2=0%;
P=0.002). There was no difference with remifentanil
(WMD 0.19; 95%CI 0.40 to 0.02; I2=82%; P=0.08)
or alfentanil (WMD 0.14; 95%CI
0.08 to 0.36;
I2=73%; P=0.21).

Secondary outcomes
Six remifentanil studies investigated the requirement for
post-delivery BVM and showed no difference (RR 1.45;
95%CI 0.88 to 2.39; I2=0%; P=0.71).10,16,20,22,25,26
Similarly there was no signiﬁcant difference in neonatal
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intubation rate with remifentanil (RR 1.34; 95%CI 0.67
to 2.68; I2=0%; P=0.97)10,16,18,20,22,25,26 or alfentanil
(RR 1.65; 95%CI 0.60 to 4.56; I2=0%; P=0.69).9,15
There was no increase in NICU admission with remifentanil (RR 0.95; 95%CI 0.77 to 1.19; I2=0%;
P=0.67).10,22,25 Only one study mentioned NICU admission following alfentanil use and showed no difference
(P=0.72).9
Ten
studies
investigated
umbilical
artery
pH7,8,10,15–18,20,22,25 and six studies investigated umbilical artery BE.7,10,18,20,22,25 There was no signiﬁcant difference in umbilical artery pH with remifentanil
(WMD 0.01; 95%CI 0.00 to 0.02; I2=33%; P=0.14),
alfentanil (WMD 0.02; 0.04 to 0.08; I2=0%; P=0.55)
or fentanyl (WMD 0.00; 95%CI
0.01 to 0.01;
I2=22%; P=0.90). Similarly, there was no signiﬁcant difference in BE with remifentanil (P=0.16) or fentanyl
(P=0.58).
Overall, there was a signiﬁcant reduction in maximum SBP (WMD 22.29 mmHg; 95%CI 27.96 to
16.61 mmHg; I2=73%; P <0.0001)8–10,16–18,20,22–24,26,
MAP (WMD
13.68 mmHg; 95%CI
19.00 to
8.36 mmHg; I2=69%; P <0.00001)8,10,17,27 and HR
(WMD 13.81 bpm; 16.92 to 10.70 bpm; I2=14%;
P <0.00001) with opioids.8–10,17,19,20,23,27 All three
agents had a similar magnitude of effect on SBP,
MAP and HR (P <0.001). Intra-operative maternal epinephrine concentrations were signiﬁcantly reduced by
remifentanil (WMD 122.56 pg/mL; 95%CI 206.20
to
38.93 pg/mL; I2=0%; P=0.0004)18,22 but not
alfentanil (WMD
29.11 pg/mL; 95%CI
127 to
69.43 pg/mL; I2=0%; P=0.56).8,15 There was no difference in intra-operative norepinephrine concentrations
with remifentanil (WMD 88.27 pg/mL;
46.76 to
223.31 pg/mL; I2=0%; P=0.20)18,22 or alfentanil
(WMD 14.78 pg/mL; 80.71 to 110.28 pg/mL; I2=0%;
P=0.76).8,15

Discussion
The use of induction opioids for CS remains a controversial topic with many theorised risks and beneﬁts.
To date, only one small meta-analysis of ﬁve RCTs
had investigated the use of remifentanil.11 This review
has expanded the topic to include studies using alfentanil and fentanyl as well as remifentanil. Our search
yielded 17 studies for inclusion.7–10,15–27 Of these, there
were 10 remifentanil, four alfentanil and three fentanyl
studies. Overall, opioids appeared not to affect neonatal
outcomes, with the exception of fentanyl which caused a
signiﬁcant reduction in ﬁve-minute Apgar scores. As
expected, all three opioids were associated with a significant reduction in maternal haemodynamic parameters.
This is in keeping with a previous small study by Rout
and Rocke28. This was the only study found in our
search that compared two different opioids for
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Study characteristics
Blinding

Patient

Induction agents

Opioid dose

Sample size
opioid:control

Primary outcome

Alfentanil
Ashton et al.15

Double blinded

Suxamethonium
4–8 mg/min
infusion and
magnesium
sulphate 30–
40 mg/kg

Alfentanil
7.5 g/kg

19:19

1.
2.
3.
4.

Apgar
Neonatal intubation
Cord pH
Maternal
epinephrine
and
norepinephrine
concentration

Dann et al.9

Double blinded

Thiopentone
3.5 mg/kg and
suxamethonium
1 mg/kg

Alfentanil
10 lg/kg

21:16

1.
2.
3.
4.
5.

Apgar
Neonatal intubation
NICU admission
Highest SBP
Highest HR

Gin et al.8

Double blinded

d Pre-eclampsia
d Elective or emergency CS
d Diastolic
BP
>90 mmHg
d Two or more
proteinuria
d Uncomplicated
pregnancy
d No medications
except iron and
folate
supplement
d No hypertension
d No
medical
conditions
d Uncomplicated
singleton
pregnancy
d Elective CS

Thiopentone
4 mg/kg and
suxamethonium
1.5 mg/kg

Alfentanil
10 lg/kg

18:22

1.
2.
3.
4.
5.

Valami et al.21

Double blinded

d Uncomplicated
pregnancy
d Age 18–40 years
d Gravida 1 or 2
d Elective CS

Thiopentone
5 mg/kg and
suxamethonium
1.5 mg/kg

Alfentanil
10 lg/kg

25:25

Remifentanil
Behdad et al.16

Double blinded

d Uncomplicated
singleton
d Term pregnancy

Thiopentone
5 mg/kg and
suxamethonium
1.5 mg/kg

Remifentanil
0.5 lg/kg bolus

40:40

Bouattour et al.25

Double blinded

d Uncomplicated
pregnancy
d Term pregnancy
d Elective
Caesarean

Propofol 2 mg/kg
an
Suxamethonium
1 mg/kg

Remifentanil
0.5 lg/kg bolus

20:20

Cord pH
Highest SBP
Highest MAP
Highest HR
Maternal
epinephrine
and
norepinephrine
concentration
1. Apgar

1.
2.
3.
4.
5.
1.
2.
3.
4.

Apgar
Neonatal BVM
Neonatal intubation
Highest SBP
Cord pH
Neonatal BVM
Neonatal intubation
NICU admission
Cord pH and BE
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Table 1
Author

Double blinded

d Uncomplicated
pregnancy
d Term pregnancy
d Elective
Caesarean

Thiopentone
4 mg/kg and
suxamethonium
1 mg/kg

Hasannasab et al.24

Double blinded

Unclear

Kart and Hanci27

Double blinded

Lee et al.23

Double blinded

Ngan Kee et al.10

Double blinded

d Uncomplicated
pregnancy
d Term pregnancy
d Elective CS
d Uncomplicated
pregnancy
d Term pregnancy
d Elective
Caesarean
d Uncomplicated
pregnancy
d Term pregnancy
d Elective
Caesarean
d Uncomplicated
pregnancy
d Term pregnancy
d Elective
Caesarean

Noskova et al.20

Double blinded

Orhan Sungur et al.26

Double blinded

Remifentanil
0.5 lg/kg before
induction,
followed by an
infusion at
0.15 lg/kg/min
until peritoneal
incision.
Remifentanil
infusion
2 lg/kg/min

21:21

1.
2.
3.
4.
5.

Apgar
Neonatal intubation
Highest SBP
Cord pH and BE
Maternal
epinephrine
and norepinephrine

50:50

1. Apgar
2. Highest SBP

Propofol 2 mg/kg
and rocuronium
0.6 mg/kg

Remifentanil
1 lg/kg bolus

30:30:30

1. Highest SBP
2. Highest HR

Thiopentone
4 mg/kg and
suxamethonium
1.5 mg/kg

Remifentanil
infusion eﬀect site
3 lg /mL

10:10

1. Apgar
2. Highest SBP
3. Highest HR

Thiopentone
4 mg/kg and
suxamethonium
1.5 mg/kg

Remifentanil
1 lg/kg bolus

20:20

d Uncomplicated
pregnancy
d Term pregnancy
d Elective
Caesarean
d Multiple
pregnancy

Thiopentone
5 mg/kg and
suxamethonium
1.25 mg/kg

Remifentanil
1 lg/kg bolus

76:75

1.
2.
3.
4.
5.
6.
7.
8.
1.
2.
3.
4.
5.

Unavailable

Thiopentone and
suxamethonium.
Doses unclear.

Remifentanil
1 lg/kg bolus

11:11

L.D. White et al.

Apgar
Neonatal BVM
Neonatal intubation
NICU admission
Highest SBP
Highest MAP
Highest HR
Cord pH and BE
Apgar
Neonatal BVM
Neonatal intubation
Highest SBP
Cord pH and BE

1. Neonatal BVM
2. Neonatal intubation
3. Highest SBP

(continued on next page)
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Author

Blinding

Patient

Induction agents

Opioid dose

Sample size
opioid:control

Yoo et al.22

Double blinded

d Severe
pre-eclamptic
women
d Elective/emergency CS

Thiopentone
4 mg/kg and
suxamethonium
1.5 mg/kg

Remifentanil
1 lg/kg bolus

21:21

1.
2.
3.
4.
5.
6.
7.

Apgar
Neonatal BVM
Neonatal intubation
NICU admission
Highest SBP
Cord pH and BE
Maternal
epinephrine
and norepinephrine

Fentanyl
Deogaonkar et al.17

Double blinded

Thiopentone
5 mg/kg and
suxamethonium
1.5 mg/kg

Fentanyl
0.5 lg/kg or
1 lg/kg bolus

15:15:15

1.
2.
3.
4.
5.

Apgar
Highest SBP
Highest MAP
Highest HR
Cord pH

Karbasy and Derakhshan19

Double blinded

d Uncomplicated
pregnancy
d Term pregnancy
d Elective or Emergency Caesarean
d Multiple
pregnancy
d Uncomplicated
pregnancy
d Term pregnancy
d Elective CS

Fentanyl 1 lg/kg
bolus

45:45

1.
2.
3.
4.

Apgar
Highest MAP
Highest HR
Cord pH

Maghsoudloo et al.7

Double blinded

Thiopentone
4 mg/kg and
suxamethonium
1.5 mg/kg
Thiopentone
5 mg/kg and
suxamethonium
1 mg/kg

Fentanyl 1 lg/kg
bolus

30:30

1. Apgar
2. Cord pH and BE

d Uncomplicated
pregnancy
d Term pregnancy
d Elective CS

Primary outcome

CS: caesarean section; BP: blood pressure; SBP: systolic blood pressure; NICU: neonatal intensive care unit; BVM: bag-mask ventilation; BE: base excess; HR: heart rate; MAP: mean arterial pressure.
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Fig. 2

The risk of bias summary for included studies

induction of CS. Their study found no statistically signiﬁcant difference between alfentanil and fentanyl for
any outcome among patients with severe pregnancyinduced hypertension.28
The sympatholytic properties of opioids are well
demonstrated in the literature and the hesitance to use
them for CS relates to the risk to the neonate.6–10 For
this reason, the primary outcome of interest was related
to neonatal adverse effects. The results of this review
showed no signiﬁcant effect on Apgar scores associated
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with remifentanil or alfentanil. There was, however, a
signiﬁcant reduction in ﬁve-minute Apgar score with
the use of fentanyl, which is likely related to the signiﬁcantly shorter duration of action of remifentanil and
alfentanil compared to fentanyl. According to a power
analysis performed by Karbasy and Derakhshan, 43
patients are needed in each group to detect a signiﬁcant
difference in Apgar scores.19 Unfortunately, the majority of studies included in this review were not adequately
powered. Of the studies that were, three investigated
remifentanil,16,20,24 and one fentanyl.19 For remifentanil
there was conﬂicting evidence regarding Apgar scores at
one minute. One study showed a signiﬁcant reduction20
but the other two showed no difference.16,24 All three
showed no difference at ﬁve minutes. In contrast to
the overall results, Karbasy and Derakhshan showed
no signiﬁcant difference in one- or ﬁve-minute Apgar
score from the use of fentanyl.19 The heterogeneity in
these ﬁndings still leads to the possibility that the overall
lack of signiﬁcance we found could be due to chance.
Apgar scores are commonly used as surrogate measures to predict subsequent adverse neonatal outcomes.
Similar to the Apgar scores, there was no signiﬁcant difference in neonatal airway intervention or NICU admission with remifentanil or alfentanil. These outcomes
were not measured in the fentanyl studies. While this
appears reassuring for those advocating the routine
use of opioids, these results should be interpreted with
caution. Previous studies have performed power analyses and determined that in order to detect a signiﬁcant
increase in airway events, 500 patients would be
required in each group.11,29,30 Therefore, all studies
included in this review are signiﬁcantly underpowered.
The studies included in this review generally included
a sufﬁcient number of patients to be adequately powered
to detect signiﬁcant differences in haemodynamic parameters and plasma catecholamine levels.16,18,22 Four studies investigated plasma catecholamine levels associated
with remifentanil and alfentanil administration. There
was a signiﬁcant reduction in plasma epinephrine, but
not norepinephrine, for remifentanil but not alfentanil.
These ﬁndings support the theory that the predominant
source of norepinephrine is from sympathetic nerves
and this is not signiﬁcantly affected by the presence of
opioids.31,32 In contrast, epinephrine is released from
the adrenal medulla and this may be modulated by systemic opioids.31,32 Although there was no attenuation
of epinephrine release with alfentanil, all three agents
demonstrated signiﬁcantly reduced haemodynamic
responses. This suggests alternative mechanisms of cardiovascular stabilisation. All three opioids resulted in a
reduced response to laryngoscopy and surgical stimulation with respect to maternal maximum HR, MAP and
SBP. More importantly, this sympatholytic effect was
demonstrated in the two studies investigating patients
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Fig. 3

Forest plot of comparison Apgar scores at one minute

Fig. 4

Forest plot of comparison Apgar scores at ﬁve minutes
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with pre-eclampsia.15,22 Both remifentanil, and alfentanil
signiﬁcantly reduced maximum HR and blood pressure
compared to the control groups.
There are several limitations to this review. The most
signiﬁcant is the lack of power to investigate neonatal
‘hard endpoints’ such as intubation and NICU admission in the studies included. Furthermore, only two
studies included at-risk pre-eclamptic patients and no
studies investigated high-risk parturients such as those
with signiﬁcant cardiac defects. Therefore, the results
of the review cannot be applied to at-risk patient
populations.
In conclusion, induction opioids are effective sympatholytic agents. Remifentanil and alfentanil appear to be
safe and without a signiﬁcant effect on Apgar scores.
There was no effect of remifentanil and alfentanil
detected in regard to neonatal airway intervention, however a large well-powered trial is still required to assess
this.
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